Aclaris Therapeutics, Inc.
0H8T.L
London Stock Exchange5.48
USD
-0.14
- -
Total Valuation
Aclaris Therapeutics, Inc. carries a market capitalization of 684.35M, placing it among publicly traded companies globally.
| Market Cap | 684.35M |
| Enterprise Value | N/A |
Stock Price Statistics
Aclaris Therapeutics, Inc.'s stock has gained approximately 275.34247% over the past 52 weeks. The 50-day moving average sits at 1.20, while the 200-day moving average is 4.31.
| Beta (5Y) | N/A |
| 52-Week Price Change | 275.34247% |
| 50-Day Moving Average | 1.20 |
| 200-Day Moving Average | 4.31 |
| Average Volume (20 Days) | N/A |